Similar Breast Cancer Risk in Women Older Than 65 Years Initiating Glargine, Detemir, and NPH Insulins.
Marie C BradleyYoganand ChillarigeHana LeeXiyuan WuShruti ParulekarMichael WerneckePatricia BrightMat SoukupThomas E MaCurdyJeffrey A KelmanDavid J GrahamPublished in: Diabetes care (2020)
Overall, glargine use was not associated with an increased risk of breast cancer compared with NPH or detemir in female Medicare beneficiaries.